Baccarani M - Search Results

1

p53 loss of function enhances genomic instability and accelerates clonal evolution of murine myeloid progenitors expressing the p(210)BCR-ABL tyrosine kinase.

Brusa G, Benvenuti M, Mazzacurati L, Mancini M, Pattacini L, Martinelli G, Barbieri E, Greenberger JS, Baccarani M, Santucci MA. Brusa G, et al. Among authors: baccarani m. Haematologica. 2003 Jun;88(6):622-30. Haematologica. 2003. PMID: 12801837

2

Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one.

Martinelli G, Amabile M, Giannini B, Terragna C, Ottaviani E, Soverini S, Saglio G, Rosti G, Baccarani M. Martinelli G, et al. Among authors: baccarani m. Haematologica. 2002 Jul;87(7):688-94; discussion 694. Haematologica. 2002. PMID: 12091118

3

Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase.

Pattacini L, Mancini M, Mazzacurati L, Brusa G, Benvenuti M, Martinelli G, Baccarani M, Santucci MA. Pattacini L, et al. Among authors: baccarani m. Leuk Res. 2004 Feb;28(2):191-202. doi: 10.1016/s0145-2126(03)00218-2. Leuk Res. 2004. PMID: 14654084

4

Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.

Mazzacurati L, Pattacini L, Brusa G, Mancini M, Benvenuti M, Barbieri E, Martinelli G, Baccarani M, Greenberger JS, Santucci MA. Mazzacurati L, et al. Among authors: baccarani m. Hematol J. 2004;5(2):168-77. doi: 10.1038/sj.thj.6200365. Hematol J. 2004. PMID: 15048068

5

New tyrosine kinase inhibitors in chronic myeloid leukemia.

Martinelli G, Soverini S, Rosti G, Cilloni D, Baccarani M. Martinelli G, et al. Among authors: baccarani m. Haematologica. 2005 Apr;90(4):534-41. Haematologica. 2005. PMID: 15820950

6

Interferon-alfa for chronic myeloid leukemia.

Baccarani M, Russo D, Rosti G, Martinelli G. Baccarani M, et al. Semin Hematol. 2003 Jan;40(1):22-33. doi: 10.1053/shem.2003.50004. Semin Hematol. 2003. PMID: 12563609 Review.

7

Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.

Rosti G, Trabacchi E, Bassi S, Bonifazi F, de Vivo A, Martinelli G, Alberti D, Fincato G, Saglio G, Baccarani M; Italian Cooperative Study Group on Chronic Myeloid Leukemia. Rosti G, et al. Among authors: baccarani m. Haematologica. 2003 Mar;88(3):256-9. Haematologica. 2003. PMID: 12651262 Clinical Trial.

8

Primary bone lymphoma: experience with 52 patients.

Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M, Stefoni V, Sabattini E, Alinari L, Binazzi R, Tura S, Baccarani M, Pileri SA. Zinzani PL, et al. Among authors: baccarani m. Haematologica. 2003 Mar;88(3):280-5. Haematologica. 2003. PMID: 12651266

9

The cytogenetic response as a surrogate marker of survival.

Rosti G, Testoni N, Martinelli G, Baccarani M. Rosti G, et al. Among authors: baccarani m. Semin Hematol. 2003 Apr;40(2 Suppl 2):56-61. doi: 10.1053/shem.2003.50042. Semin Hematol. 2003. PMID: 12783377 Review.

10

Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.

Martinelli G, Malagola M, Ottaviani E, Rosti G, Trabacchi E, Baccarani M. Martinelli G, et al. Among authors: baccarani m. Haematologica. 2004 Feb;89(2):236-7. Haematologica. 2004. PMID: 15003901 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters